The Chinese Society of Clinical Oncology (CSCO) 2020 annual meeting was held on September 19-26, 2020. The format was mostly online, but the virtual meeting was supplemented by on-site participation in the cities of Beijing, Shanghai, Wuhan, Harbin and Guangzhou, in order to meet the requirements of the COVID-19 epidemic prevention and control. The CSCO 2020 theme was "Precision Treatment, Win-Win Together," promoting academic exchanges and technical cooperation on scientific research and innovation to encourage precision oncology based on multidisciplinary standardized comprehensive treatment. The annual meeting continued to have focused sessions on Frontiers of Oncology Clinical Research, Center for Drug Evaluation (CDE), which jointly build technical standards to accelerate the development and launch of new antitumor drugs, and Innovative Drug Clinical Research Data. This report focuses on discussions in the CDE session and provides highlights on the clinical data presented in the Innovative Drug session.